Literature DB >> 468791

Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus.

M D Challberg, P T Englund.   

Abstract

The vaccinia virus-induced DNA polymerase has been purified about 500-fold from a cytoplasmic extract of vaccinia-infected HeLa cells. Analysis of the purified fraction by sodium dodecyl sulfate-polyacrylamide gel electrophoresis reveals a single polypeptide of 110,000 daltons, which is greater than 95% pure. This polypeptide co-sediments with polymerase activity through a glycerol gradient. The sedimentation coefficient of the enzyme is 6.3 S, and its Stokes radius is 4.6 nm. The molecular weight of the native enzyme derived from these values is 115,000. Vaccinia polymerase is therefore a single large polypeptide of 110,000 to 115,000 daltons. The purified fraction has no significant endonuclease activity, but a strong exonuclease activity co-purifies with polymerase activity through every step in the isolation. The polymerase and exonuclease activities are inactivated at 45 degrees C at the same rate. It is likely, therefore, that both activities are catalyzed by the same polypeptide. The exonuclease hydrolyzes DNA predominantly in the 3' leads to 5' direction, to produce 5' mononucleotides. The exonuclease degrades single-stranded DNA more rapidly than duplex DNA, and the rate of digestion of both single-stranded and double-stranded DNA increases as the size of the substrate decreases. Single-stranded circular DNA is a potent inhibitor of the exonuclease activity, but duplex circular DNA has no significant effect on its activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity.

Authors:  A Punjabi; K Boyle; J DeMasi; O Grubisha; B Unger; M Khanna; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases.

Authors:  G L Smith; Y S Chan; S M Kerr
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  Betalactam antibiotics interfere with eukaryotic DNA-replication by inhibiting DNA polymerase alpha.

Authors:  U H Do; K A Neftel; S Spadari; U Hübscher
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

4.  Enzymatic processing of replication and recombination intermediates by the vaccinia virus DNA polymerase.

Authors:  Michael D Hamilton; David H Evans
Journal:  Nucleic Acids Res       Date:  2005-04-20       Impact factor: 16.971

5.  Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression.

Authors:  W F McDonald; V Crozel-Goudot; P Traktman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Heteroduplex DNA formation is associated with replication and recombination in poxvirus-infected cells.

Authors:  C Fisher; R J Parks; M L Lauzon; D H Evans
Journal:  Genetics       Date:  1991-09       Impact factor: 4.562

Review 7.  Poxvirus DNA replication.

Authors:  Bernard Moss
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 8.  The vaccinia virus DNA polymerase and its processivity factor.

Authors:  Maciej W Czarnecki; Paula Traktman
Journal:  Virus Res       Date:  2017-02-01       Impact factor: 3.303

9.  Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping.

Authors:  G L Smith; A de Carlos; Y S Chan
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

10.  Effect of aphidicolin on vaccinia virus: isolation of an aphidicolin-resistant mutant.

Authors:  F M DeFilippes
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.